Nebenwirkungen · Elebrato Ellipta
Elebrato Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder, pre-dispensed · Abschnitt 4.8 · PDF-Seite 8
HOS-141960 · Präparat HOS-098720
Infections and infestations Pneumonia Common Upper respiratory tract infection Bronchitis Pharyngitis Rhinitis Sinusitis Influenza Nasopharyngitis Candidiasis of mouth and throat Urinary tract infection Viral respiratory tract infection Uncommon Immune system disorders Hypersensitivity reactions, including Rare anaphylaxis, angioedema, urticaria, and rash Metabolism and nutrition Hyperglycaemia Rare disorders Psychiatric disorders Anxiety Rare Nervous system disorders Headache Common Dysgeusia Uncommon Tremor Rare Eye disorders Vision blurred (see section 4.4) Uncommon Glaucoma Eye pain Intraocular pressure increased Rare Cardiac disorders Supraventricular tachyarrhythmia Uncommon Tachycardia Atrial fibrillation Palpitations Rare Respiratory, thoracic & Cough Common mediastinal disorders Oropharyngeal pain Dysphonia Uncommon Gastrointestinal disorders Constipation Common Dry mouth Uncommon Musculoskeletal and Arthralgia Common connective tissue disorders Back pain Fractures Uncommon Muscle spasms Rare Renal and urinary disorders Urinary retention Rare Dysuria
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-08T12:09:00Z · SHA-256 5921a8b45eff5f6f74f973b971b75b80cf50431a4e47b20e906f127e6f0ef9a0 · Passage 62e7f62b383785902dbc89b57d7e3299103060f4b62bcb50297447876bfed155 · Zeichen 894–3563 im Abschnitt